Form 4: Twist Bioscience CEO Sells Shares

Sentiment:

Insider Transaction (Form 4)


Emily M. Leproust, Chief Executive Officer and a Director of Twist Bioscience Corp, sold 113,318 shares of common stock on August 10, 2026 for $125.16 per share.

Summary

  • Option exercise/conversion: acquired 113,318 Common Stock at $26.66 ($3,021,058) on August 10, 2026; holds 932,256 after (Direct).
  • Open-market sale: disposed of 113,318 Common Stock at $125.16 ($14,183,051) on August 10, 2026; holds 818,938 after (Direct).
  • Option exercise/conversion: disposed of 113,318 Employee Stock Option (right to buy) on August 10, 2026; holds 153,221 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $14,183,051 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Emily M. Leproust — Director, Officer (Chief Executive Officer)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-08-10Option exercise/conversionCommon Stock113,318$27$3.0M932,256
2026-08-10Open-market saleCommon Stock113,318$125$14.2M818,938
2026-08-10Option exercise/conversionEmployee Stock Option (right to buy)113,318——153,221

Key Dates

DateDescription
2026-08-10Option exercise/conversion (113,318 shares)
2026-08-10Open-market sale (113,318 shares)
2026-08-10Option exercise/conversion (113,318 shares)

Keywords

insider transaction, Form 4, TWST, Twist Bioscience Corp, bearish, Emily M. Leproust

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.